GSI 7977 (Sovaldi 400 mg)
Generic Name: sofosbuvir
This pill with imprint "GSI 7977" is Yellow, Capsule-shape and has been identified as Sovaldi 400 mg. It is manufactured by Gilead Sciences, Inc..
Sovaldi is used in the treatment of hepatitis c and belongs to the drug class miscellaneous antivirals. There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sofosbuvir
- Imprint:
- GSI 7977
- Strength:
- 400 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antivirals
- Pregnancy Category:
- B - No proven risk in humans
X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin - CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Gilead Sciences, Inc.
More about Sovaldi (sofosbuvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 43 Reviews – Add your own review/rating
- Drug class: miscellaneous antivirals
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
